Testimonials
MAN, i went thru those 30 tablets like nothing, WHEW, they were great. I could really use the other 60. I have to say your pills are one of the better generic viagras I have expereienced so far on my comeback trail. do you offer the the much quicker and more flavorful melt tabs. if you do, I would like to possibly upgrade on the remaining 60 (if they have not been shipped yet) It all depends on the price difference, just let me know. maybe we can work something out. - glenn
Call us toll free:
News
- UCL spinout takes nano-enabled pain therapy to international markets - MTBeurope
UCL spinout takes nano-enabled pain therapy to international marketsMTBeuropeThe UK Nanotechnology Knowledge Transfer Network (NanoKTN) has announced that member company Nanomerics, a spin-out from UCL School of Pharmacy, is taking its patented nano-enabled therapeutic technology to international markets.
- Skepticism grows around Medco/Express Scripts deal - Reuters
WGN RadioSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the .
- Applied DNA Sciences installs first pharmacy security system - Securing Pharma
Applied DNA Sciences installs first pharmacy security systemSecuring PharmaApplied DNA Sciences has installed its smartDNA anti-intruder mist system at a pharmacy in Long Island, USA, in response to a spate of pharmacy robberies there in recent months.
- Memo offers new account of ATF agent's NY shooting - USA TODAY
USA TODAYMemo offers new account of ATF agent's NY shootingUSA TODAYGARDEN CITY, NJ (AP) – A document accidentally posted on a prosecutor's website cites a pharmacist's version of the friendly fire shooting death of a federal agent during a New Year's Eve robbery and differs from an account offered by an attorney for .
- FDA approves first Cushing's syndrome drug, Corcept's Korlym - The Pharma Letter
FDA approves first Cushing's syndrome drug, Corcept's KorlymThe Pharma LetterShares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
 | Sitemap |
|---|
Our billing is certified by:
We accept:
